LEIDY CARABALLO GALVA to Immunotherapy, Adoptive
This is a "connection" page, showing publications LEIDY CARABALLO GALVA has written about Immunotherapy, Adoptive.
Connection Strength
0.514
-
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma. J Genet Genomics. 2020 01 20; 47(1):1-15.
Score: 0.373
-
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity. Mol Ther. 2026 Apr 01; 34(4):2154-2174.
Score: 0.141